Discover 1,239 paid clinical trials in Murfreesboro, Tennessee. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,239
Active & Responsive
PrP-targeting siRNA Safety & Mechanism Study
for
Prion Disease
Location: Nashville TN, Cleveland OH, Rochester MN, New York NY,
Sponsor: Broad Institute of MIT and Harvard
Sex: All
Age: 18+
Code: NCT07444580
Phase 1, Recruiting
Active & Responsive
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
for
Short Bowel Syndrome
Location: Nashville TN, St Louis MO, Chicago IL, Pittsburgh PA,
Sponsor: Zealand Pharma
Sex: All
Age: 18 - 70+
Code: NCT07197944
Phase 3, Recruiting
Active & Responsive
A Study of JNT-517 in Participants With Phenylketonuria (PKU)
for
Phenylketonuria
Location: Nashville TN, Chicago IL, Pittsburgh PA, Gainesville FL,
Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Sex: All
Age: 4+
Code: NCT06971731
Phase 3, Recruiting
Active & Responsive
Sibwatch: Optimizing Intervention Options for Infants and Toddler Siblings of Autistic Children
for
Autism Sibling
Location: Nashville TN, Austin TX
Sponsor: University of Texas at Austin
Sex: All
Age: 0 - 2
Code: NCT07069413
Recruiting
Active & Responsive
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: Nashville TN, Augusta GA, Detroit MI, Fairfax VA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
for
Metastatic Dedifferentiated Liposarcoma,
Location: Nashville TN, Louisville KY, Atlanta GA, Centralia IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06422806
Phase 3, Recruiting
Active & Responsive
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Nashville TN, Louisville KY, Atlanta GA, Lexington KY,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT04671667
Phase 2, Recruiting
Active & ResponsiveNew
Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma
for
Cutaneous Melanoma
Location: Nashville TN, Bardstown KY, Corbin KY, London KY,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 70+
Code: NCT07068074
Phase 3, Recruiting
Active & Responsive
FOG-001 in Locally Advanced or Metastatic Solid Tumors